AMESBURY, Mass.--(BUSINESS WIRE)--Ivenix, Inc., a medical technology company developing a next-generation infusion management platform, announced today that the company will participate in The HIMSS Interoperability Showcase™ during the 2016 HIMSS Conference & Exhibition at the Sands Expo Convention Center in Las Vegas, Nevada from February 29 to March 4, 2016.
“We are thrilled to be a part of the HIMSS Interoperability Showcase, as it provides an opportunity to demonstrate the Ivenix Infusion Management System in a wide breadth of care settings,” said Stuart Randle, chief executive officer of Ivenix. “We’ve worked closely with clinicians to better understand their workflow, and they have been instrumental in the development of the platform that we expect will improve patient safety and workflow efficiency.”
The HIMSS Interoperability Showcase is an interactive, vendor-neutral environment with real-world clinical use cases that demonstrate the significance of interoperable devices and information systems’ potential to change the future of healthcare. Experts will discuss how to solve complex healthcare problems around system and device implementation to move interoperability initiatives forward.
The Ivenix Infusion Management System will be featured in a live collaboration with leading EMR and Health IT vendors, demonstrating interoperability to manage patient-specific infusion orders and integrate this data seamlessly to the patient record.
“Participating in this year’s Interoperability Showcase shows our commitment to standards-based interoperability to support improved patient outcomes across healthcare settings,” said George Gray, chief technology officer and vice president of IT & Software Systems. “The Ivenix Infusion Management System has been architected to actively manage patient-specific infusion information while easily enabling interoperability with other information systems.”
The Interoperability Showcase is located in Booth #11954, Exhibit Hall G, Level 1. The Ivenix Infusion Management System is featured in Use Case #4: Cancer Care Research & Reporting.
About the Ivenix Infusion Management System
While drug therapies have become more complex and effective, infusion pumps on the market today heavily rely on legacy technology that can be error prone, difficult to operate and ultimately lead to workflow inefficiencies and use errors that affect patient safety. The errors alone are estimated to add $2 billion per year to the cost of U.S. healthcare.
